Heimdall Insights

Global Zika and West Nile Virus Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Zika and West Nile Virus Therapeutics Market was valued at $20.7 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.3% CAGR, to an estimated market size of $26.8 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Global Zika and West Nile Virus Therapeutics Market encompasses the development, manufacturing, and distribution of preventive vaccines, antiviral drugs, and symptomatic treatments (such as analgesics and NSAIDs) specifically indicated for infections caused by the Zika and West Nile flaviviruses. The scope includes antibody-based therapies, molecular diagnostics, and emerging mRNA-based prophylactic solutions, while excluding general pest control services and non-specific hospital care costs.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Zika and West Nile Virus Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Segments

  • Vaccines (Preventive & Therapeutic)
  • Antivirals & Symptomatic Drugs
  • Diagnostics & Other